Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
625 A phase 1 single ascending dose study evaluating the safety, tolerability, and pharmacodynamic effects of MDK-703, an IL-7 mimetic with extended half-life
Compose a Response to This Article
Other responses
No responses have been published for this article.